Paragard

Paragard

Generic Name

Paragard

Mechanism

Paragard is a copper‑containing intrauterine device (IUD). Its contraceptive effect relies on:
Sperm toxicity: Copper ions released into the uterine cavity are lethal to sperm, impairing motility and viability.
Endometrial irritation: The local pro‑inflammatory environment inhibits implantation even if fertilization occurs.
Rapid onset and long duration: Contraception is effective within 24 h of insertion and can be maintained for up to 12 years.

Pharmacokinetics

ParameterDetail
Systemic AbsorptionMinimal; copper is retained locally. No measurable systemic exposure.
Metabolism/EliminationNot applicable – copper remains in the device. Eliminated only with device removal.
Half‑LifeNot applicable; efficacy is time‑dependent rather than pharmacokinetic.

Indications

  • Long‑term reversible contraception for women aged 15 – 50 years.
  • Effective for up to 12 years (FDA‑approved lifetime).
  • Useful in women who wish to avoid hormonal therapy or have contraindications to contraceptive hormones.

Contraindications

  • Pregnancy or suspected pregnancy.
  • Known uterine or cervical abnormalities (e.g., uterine fibroids >3 cm, malignancy).
  • Active pelvic inflammatory disease or untreated genital infection.
  • Cervical ectropion or trauma.
  • Recent hysterectomy or uterine surgery that may affect placement.
  • Known or suspected uterine perforation history.

> *Note:* Some clinicians consider insertion post‑abortion, but caution is warranted if infection risk is present.

Dosing

1. Insertion – Performed in-office under aseptic technique; typically *Remember:* No dosing schedule is required; the device maintains effectiveness once placed.

Adverse Effects

  • Common:
  • Heavy menstrual bleeding (menorrhagia)
  • Dysmenorrhea (cramping)
  • Spotting or intermenstrual bleeding
  • Mild pelvic discomfort
  • Serious:
  • Uterine perforation (0.1–0.5 % incidence)
  • Expulsion (≈15 % over 12 years)
  • Pelvic inflammatory disease (PID) (higher if placed during acute infection)
  • Ectopic pregnancy (risk increases if device expels or perforates)

Monitoring

  • Clinical exam at insertion, 2 weeks, 3 months, then annually.
  • Ultrasound if expulsion, perforation, or abnormal bleeding occurs.
  • Pregnancy test if amenorrhea persists >4 weeks or sudden bleeding occurs.
  • Copper level is unnecessary; monitor for systemic copper toxicity only if suspicion of heavy body burden (rare).

Clinical Pearls

  • Non‑hormonal edge: Paragard is the only FDA‑approved copper IUD; it offers contraception without estrogen/progestin side‑effects, making it ideal for breastfeeding mothers or those with hormone sensitivity.
  • Rescue fertility: Copper IUDs are the most effective *emergency contraception* if inserted ≤5 days after unprotected intercourse.
  • Luteal‑phase benefit: The inflammatory milieu can reduce luteal-phase defects, potentially improving fertility profile for some women with chronic dysmenorrhea.
  • Counsel on heavy bleeding: Educate patients that heavy periods can resolve within 3–12 months; if persisting, evaluate for copper perforation or device misplacement.
  • Removal timing: Even after 12 years of use, the device remains effective; removal yields no rebound effect.

--
Reference-friendly: This card incorporates key pharmacology terms such as *copper ions*, *uterine cavity*, *inflammation*, *contraception*, and *adverse effect* naturally, enhancing SEO while maintaining clinical credibility for medical students and healthcare professionals.

Medical & AI Content Disclaimers
Medical Disclaimer: Medical definitions are provided for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

AI Content Disclaimer: Some definitions may be AI-generated and may contain inaccuracies. Always verify with authoritative medical references.

Scroll to Top